Details for: H2AZ1

Gene ID: 3015

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: H2AZ1

Ensembl ID: ENSG00000164032

Description: H2A.Z variant histone 1

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • granulocyte monocyte progenitor cell CL0000557
    CSI 114.76
    rCSI 99.37%
    PRS 3.35
  • common myeloid progenitor CL0000049
    CSI 114.49
    rCSI 92.57%
    PRS 2.94
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 96.45
    rCSI 87.1%
    PRS 2.63
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 94.19
    rCSI 100%
    PRS 2.78
  • keratinocyte CL0000312
    CSI 90.03
    rCSI 75.46%
    PRS 3.61
  • pro-B cell CL0000826
    CSI 86.95
    rCSI 72.01%
    PRS 3
  • hematopoietic stem cell CL0000037
    CSI 84.98
    rCSI 56.49%
    PRS 3.57
  • transit amplifying cell of colon CL0009011
    CSI 73.95
    rCSI 86.85%
    PRS 3.66
  • early lymphoid progenitor CL0000936
    CSI 72.18
    rCSI 63.4%
    PRS 3.35
  • common dendritic progenitor CL0001029
    CSI 68.96
    rCSI 86.55%
    PRS 3.8
  • radial glial cell CL0000681
    CSI 68.86
    rCSI 95.67%
    PRS 3.19
  • promyelocyte CL0000836
    CSI 68.63
    rCSI 98.98%
    PRS 4.16
  • fallopian tube secretory epithelial cell CL4030006
    CSI 67.54
    rCSI 65.01%
    PRS 3.13
  • fraction A pre-pro B cell CL0002045
    CSI 67.45
    rCSI 77.21%
    PRS 6.25
  • epithelial cell of lung CL0000082
    CSI 65.62
    rCSI 54.4%
    PRS 2.81
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 65.17
    rCSI 50.21%
    PRS 2.7
  • multi-ciliated epithelial cell CL0005012
    CSI 63.74
    rCSI 63.61%
    PRS 2.53
  • ciliated epithelial cell CL0000067
    CSI 62.42
    rCSI 54.89%
    PRS 2.18
  • plasmablast CL0000980
    CSI 61.29
    rCSI 48.21%
    PRS 3.56
  • pancreatic A cell CL0000171
    CSI 60.37
    rCSI 63.25%
    PRS 3.24
  • OFF-bipolar cell CL0000750
    CSI 59.48
    rCSI 81.32%
    PRS 5.46
  • pancreatic D cell CL0000173
    CSI 58.4
    rCSI 57.44%
    PRS 3.32
  • mesodermal cell CL0000222
    CSI 56.66
    rCSI 68.01%
    PRS 3
  • peripheral nervous system neuron CL2000032
    CSI 54.93
    rCSI 74.85%
    PRS 2.71
  • neural crest cell CL0011012
    CSI 54.65
    rCSI 43.2%
    PRS 2.08
  • promonocyte CL0000559
    CSI 52.18
    rCSI 89.4%
    PRS 4
  • placental villous trophoblast CL2000060
    CSI 51.73
    rCSI 79.93%
    PRS 2.82
  • enteric smooth muscle cell CL0002504
    CSI 50.47
    rCSI 72.03%
    PRS 3.43
  • intestinal epithelial cell CL0002563
    CSI 48.5
    rCSI 50.69%
    PRS 3.2
  • extravillous trophoblast CL0008036
    CSI 47.4
    rCSI 58.64%
    PRS 2.63
  • ON-bipolar cell CL0000749
    CSI 46.64
    rCSI 69.32%
    PRS 3.98
  • transit amplifying cell CL0009010
    CSI 44.73
    rCSI 68.42%
    PRS 4.91
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 42.22
    rCSI 54.19%
    PRS 3.01
  • glioblast CL0000030
    CSI 40.14
    rCSI 64.03%
    PRS 2.64
  • melanocyte CL0000148
    CSI 39.66
    rCSI 29.37%
    PRS 2.84
  • intestine goblet cell CL0019031
    CSI 38.73
    rCSI 34.38%
    PRS 3
  • myeloid leukocyte CL0000766
    CSI 38
    rCSI 35.06%
    PRS 3.03
  • common lymphoid progenitor CL0000051
    CSI 37.14
    rCSI 49.63%
    PRS 5.74
  • interstitial cell of Cajal CL0002088
    CSI 36.06
    rCSI 45.91%
    PRS 3.51
  • elicited macrophage CL0000861
    CSI 35.25
    rCSI 32.37%
    PRS 3.41
  • conventional dendritic cell CL0000990
    CSI 34.23
    rCSI 28.58%
    PRS 9.96
  • colon epithelial cell CL0011108
    CSI 33.25
    rCSI 34.84%
    PRS 2.8
  • enteroendocrine cell CL0000164
    CSI 31.16
    rCSI 42.57%
    PRS 3.32
  • large pre-B-II cell CL0000957
    CSI 30.95
    rCSI 88.35%
    PRS 5.32
  • dendritic cell, human CL0001056
    CSI 29.7
    rCSI 45.61%
    PRS 3.47
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 29.56
    rCSI 55.88%
    PRS 6.83
  • progenitor cell CL0011026
    CSI 29.31
    rCSI 62.34%
    PRS 5.98
  • mucous neck cell CL0000651
    CSI 28.67
    rCSI 41.32%
    PRS 4.88
  • epithelial cell CL0000066
    CSI 28.43
    rCSI 43.69%
    PRS 4.37
  • precursor B cell CL0000817
    CSI 28.28
    rCSI 24.77%
    PRS 4.05
  • forebrain radial glial cell CL0013000
    CSI 28.27
    rCSI 90.72%
    PRS 4.59
  • type B pancreatic cell CL0000169
    CSI 27.98
    rCSI 61.95%
    PRS 2.82
  • Langerhans cell CL0000453
    CSI 27.44
    rCSI 41.91%
    PRS 5.26
  • deuterosomal cell CL4033044
    CSI 27.22
    rCSI 92.02%
    PRS 5.18
  • tracheal goblet cell CL1000329
    CSI 26.48
    rCSI 57.81%
    PRS 6.16
  • luminal epithelial cell of mammary gland CL0002326
    CSI 25.02
    rCSI 45.46%
    PRS 4.61
  • alveolar macrophage CL0000583
    CSI 24.18
    rCSI 39.83%
    PRS 3.47
  • respiratory suprabasal cell CL4033048
    CSI 24.15
    rCSI 30.97%
    PRS 3.46
  • stromal cell of ovary CL0002132
    CSI 23.64
    rCSI 64.96%
    PRS 5.08
  • respiratory basal cell CL0002633
    CSI 23.63
    rCSI 24.48%
    PRS 3.51
  • pancreatic acinar cell CL0002064
    CSI 23.59
    rCSI 31.35%
    PRS 3.29
  • germinal center B cell CL0000844
    CSI 23.35
    rCSI 69.64%
    PRS 8.25
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 22.92
    rCSI 27.69%
    PRS 3.46
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 22.63
    rCSI 23.07%
    PRS 4.36
  • brush cell of tracheobronchial tree CL0002075
    CSI 22.51
    rCSI 66.8%
    PRS 5.31
  • microcirculation associated smooth muscle cell CL0008035
    CSI 22.34
    rCSI 64.68%
    PRS 3.41
  • muscle cell CL0000187
    CSI 21.36
    rCSI 43.85%
    PRS 7.35
  • foveolar cell of stomach CL0002179
    CSI 21.25
    rCSI 45.23%
    PRS 4.9
  • kidney epithelial cell CL0002518
    CSI 21.02
    rCSI 40.12%
    PRS 7.43
  • respiratory hillock cell CL4030023
    CSI 20.81
    rCSI 37.1%
    PRS 5.21
  • mammary gland epithelial cell CL0002327
    CSI 20.16
    rCSI 70.72%
    PRS 5.46
  • goblet cell CL0000160
    CSI 19.74
    rCSI 18.65%
    PRS 3.13
  • conjunctival epithelial cell CL1000432
    CSI 19.57
    rCSI 29.89%
    PRS 3.03
  • Hofbauer cell CL3000001
    CSI 18.53
    rCSI 34.98%
    PRS 3.73
  • transit amplifying cell of small intestine CL0009012
    CSI 18.44
    rCSI 80.96%
    PRS 5.94
  • CD4-positive helper T cell CL0000492
    CSI 17.62
    rCSI 13.33%
    PRS 4.2
  • colon goblet cell CL0009039
    CSI 17.53
    rCSI 41.66%
    PRS 4.59
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 17.52
    rCSI 47.22%
    PRS 3.95
  • glandular epithelial cell CL0000150
    CSI 17.16
    rCSI 45.18%
    PRS 5.9
  • cerebral cortex GABAergic interneuron CL0010011
    CSI 17.15
    rCSI 50.62%
    PRS 3.94
  • group 3 innate lymphoid cell CL0001071
    CSI 16.81
    rCSI 12.63%
    PRS 3.08
  • endothelial cell of placenta CL0009092
    CSI 16.54
    rCSI 81.53%
    PRS 4.12
  • dendritic cell CL0000451
    CSI 16.32
    rCSI 20.11%
    PRS 10.01
  • retinal cone cell CL0000573
    CSI 15.88
    rCSI 25.56%
    PRS 2.37
  • skin fibroblast CL0002620
    CSI 15.88
    rCSI 13.69%
    PRS 5.02
  • basophil mast progenitor cell CL0002028
    CSI 15.77
    rCSI 84.14%
    PRS 7.75
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 15.52
    rCSI 60.42%
    PRS 4.97
  • eosinophil CL0000771
    CSI 15.34
    rCSI 100%
    PRS 7.92
  • erythroblast CL0000765
    CSI 15.27
    rCSI 40.52%
    PRS 5.23
  • pulmonary ionocyte CL0017000
    CSI 15.26
    rCSI 18.57%
    PRS 3.8
  • T follicular helper cell CL0002038
    CSI 15.2
    rCSI 11.38%
    PRS 4.92
  • pancreatic PP cell CL0002275
    CSI 15.11
    rCSI 60.15%
    PRS 5.49
  • CD8-alpha-alpha-positive, alpha-beta intraepithelial T cell CL0000915
    CSI 15.03
    rCSI 68.34%
    PRS 11.47
  • erythroid progenitor cell CL0000038
    CSI 14.96
    rCSI 85.8%
    PRS 4.73
  • type EC enteroendocrine cell CL0000577
    CSI 14.9
    rCSI 52.9%
    PRS 4.96
  • neural progenitor cell CL0011020
    CSI 14.35
    rCSI 63.12%
    PRS 3.12
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 14.27
    rCSI 34.35%
    PRS 4.75
  • retinal rod cell CL0000604
    CSI 14.25
    rCSI 25.11%
    PRS 3.42
  • lung endothelial cell CL1001567
    CSI 14.21
    rCSI 33.14%
    PRS 8.24
  • mesenchymal cell CL0008019
    CSI 14.06
    rCSI 35.71%
    PRS 3.07
  • alpha-beta T cell CL0000789
    CSI -53.3
    rCSI -62.4%
    PRS 5.0%
  • pvalb GABAergic cortical interneuron CL4023018
    CSI -33.3
    rCSI -41.5%
    PRS 1.7%
  • vascular leptomeningeal cell CL4023051
    CSI -16.0
    rCSI -28.0%
    PRS 2.4%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI -10.7
    rCSI -18.9%
    PRS 1.9%
  • astrocyte of the cerebral cortex CL0002605
    CSI -10.5
    rCSI -23.5%
    PRS 2.0%
  • platelet CL0000233
    CSI -8.0
    rCSI -33.3%
    PRS 9.4%
  • inhibitory interneuron CL0000498
    CSI -7.3
    rCSI -16.8%
    PRS 2.9%
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI -7.2
    rCSI -26.1%
    PRS 1.6%
  • lung interstitial macrophage CL4033043
    CSI -6.7
    rCSI -15.1%
    PRS 7.8%
  • naive T cell CL0000898
    CSI -6.7
    rCSI -4.7%
    PRS 4.4%
  • hepatic stellate cell CL0000632
    CSI -6.5
    rCSI -24.2%
    PRS 2.6%
  • serous secreting cell CL0000313
    CSI -6.0
    rCSI -30.1%
    PRS 15.9%
  • sncg GABAergic cortical interneuron CL4023015
    CSI -5.7
    rCSI -9.2%
    PRS 2.2%
  • neural cell CL0002319
    CSI -4.9
    rCSI -18.5%
    PRS 6.8%
  • L6b glutamatergic cortical neuron CL4023038
    CSI -4.7
    rCSI -14.7%
    PRS 2.0%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI -4.6
    rCSI -7.7%
    PRS 1.9%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI -4.5
    rCSI -5.4%
    PRS 5.3%
  • exhausted T cell CL0011025
    CSI -4.3
    rCSI -71.9%
    PRS 16.4%
  • Schwann cell CL0002573
    CSI -4.0
    rCSI -11.5%
    PRS 4.2%
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI -3.9
    rCSI -14.7%
    PRS 2.0%
  • Kupffer cell CL0000091
    CSI -3.8
    rCSI -8.8%
    PRS 2.9%
  • sst GABAergic cortical interneuron CL4023017
    CSI -3.4
    rCSI -4.3%
    PRS 2.0%
  • lung pericyte CL0009089
    CSI -3.2
    rCSI -8.4%
    PRS 3.6%
  • cerebral cortex neuron CL0010012
    CSI -2.9
    rCSI -11.8%
    PRS 3.8%
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI -2.7
    rCSI -8.4%
    PRS 2.2%
  • corticothalamic-projecting glutamatergic cortical neuron CL4023013
    CSI -2.5
    rCSI -14.9%
    PRS 2.1%
  • adipocyte CL0000136
    CSI -2.2
    rCSI -2.8%
    PRS 4.0%
  • diffuse bipolar 2 cell CL4033028
    CSI -2.0
    rCSI -15.2%
    PRS 6.6%
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI -1.8
    rCSI -1.7%
    PRS 4.7%
  • OFFx cell CL4033036
    CSI -1.5
    rCSI -6.9%
    PRS 6.6%
  • diffuse bipolar 3b cell CL4033030
    CSI -1.5
    rCSI -9.6%
    PRS 6.4%
  • VIP GABAergic cortical interneuron CL4023016
    CSI -1.4
    rCSI -1.7%
    PRS 1.9%
  • retinal bipolar neuron CL0000748
    CSI -1.3
    rCSI -2.4%
    PRS 2.4%
  • ON midget ganglion cell CL4033046
    CSI -1.1
    rCSI -22.2%
    PRS 3.4%
  • OFF midget ganglion cell CL4033047
    CSI -1.1
    rCSI -22.1%
    PRS 3.7%
  • alveolar type 1 fibroblast cell CL4028004
    CSI -0.9
    rCSI -1.0%
    PRS 3.5%
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI -0.8
    rCSI -2.0%
    PRS 1.9%
  • alveolar adventitial fibroblast CL4028006
    CSI -0.8
    rCSI -1.2%
    PRS 3.0%
  • kidney resident macrophage CL1000698
    CSI -0.7
    rCSI -13.9%
    PRS 63.0%
  • diffuse bipolar 3a cell CL4033029
    CSI -0.5
    rCSI -3.6%
    PRS 6.3%
  • H2 horizontal cell CL0004218
    CSI -0.4
    rCSI -1.9%
    PRS 5.4%
  • endothelial cell of arteriole CL1000412
    CSI -0.2
    rCSI -1.1%
    PRS 15.8%
  • GABAergic amacrine cell CL4030027
    CSI -0.1
    rCSI -0.4%
    PRS 4.0%
  • H1 horizontal cell CL0004217
    CSI -0.1
    rCSI -0.3%
    PRS 7.7%
  • parietal cell CL0000162
    CSI 0.1
    rCSI 0.8%
    PRS 21.5%
  • B-2 B cell CL0000822
    CSI 0.1
    rCSI 3.0%
    PRS 19.6%
  • osteoblast CL0000062
    CSI 0.2
    rCSI 4.9%
    PRS 29.3%
  • enteroglial cell CL4040002
    CSI 0.2
    rCSI 1.2%
    PRS 7.8%
  • brush cell CL0002204
    CSI 0.3
    rCSI 0.5%
    PRS 8.9%
  • ventricular cardiac muscle cell CL2000046
    CSI 0.3
    rCSI 1.1%
    PRS 14.3%
  • enterocyte of epithelium of small intestine CL1000334
    CSI 0.4
    rCSI 5.7%
    PRS 8.1%
  • colon macrophage CL0009038
    CSI 0.4
    rCSI 1.7%
    PRS 6.8%
  • immature alpha-beta T cell CL0000790
    CSI 0.4
    rCSI 5.4%
    PRS 46.4%
  • decidual natural killer cell, human CL0002343
    CSI 0.4
    rCSI 4.0%
    PRS 28.9%
  • collagen secreting cell CL0000667
    CSI 0.5
    rCSI 2.6%
    PRS 17.9%
  • B-1 B cell CL0000819
    CSI 0.5
    rCSI 11.5%
    PRS 18.3%
  • kidney connecting tubule epithelial cell CL1000768
    CSI 0.5
    rCSI 1.2%
    PRS 2.4%
  • retinal ganglion cell CL0000740
    CSI 0.5
    rCSI 1.0%
    PRS 2.2%
  • double negative T regulatory cell CL0011024
    CSI 0.5
    rCSI 9.1%
    PRS 27.3%
  • myoepithelial cell CL0000185
    CSI 0.5
    rCSI 1.2%
    PRS 3.8%
  • cytotoxic T cell CL0000910
    CSI 0.6
    rCSI 3.2%
    PRS 4.8%
  • tracheobronchial smooth muscle cell CL0019019
    CSI 0.6
    rCSI 1.0%
    PRS 4.0%
  • glycinergic amacrine cell CL4030028
    CSI 0.6
    rCSI 1.6%
    PRS 4.4%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 0.7
    rCSI 3.4%
    PRS 3.9%
  • endothelial cell of venule CL1000414
    CSI 0.7
    rCSI 6.4%
    PRS 19.9%
  • endothelial cell of vascular tree CL0002139
    CSI 0.8
    rCSI 4.4%
    PRS 8.0%
  • mast cell CL0000097
    CSI 0.8
    rCSI 1.8%
    PRS 18.1%
  • corneal epithelial cell CL0000575
    CSI 0.9
    rCSI 2.4%
    PRS 6.0%
  • regular atrial cardiac myocyte CL0002129
    CSI 0.9
    rCSI 2.8%
    PRS 3.8%
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 1.0
    rCSI 2.7%
    PRS 4.4%
  • blood vessel smooth muscle cell CL0019018
    CSI 1.0
    rCSI 7.8%
    PRS 3.2%
  • uterine smooth muscle cell CL0002601
    CSI 1.0
    rCSI 6.6%
    PRS 23.9%
  • serous secreting cell of bronchus submucosal gland CL4033005
    CSI 1.0
    rCSI 5.8%
    PRS 17.7%
  • basal cell of epidermis CL0002187
    CSI 1.2
    rCSI 2.2%
    PRS 4.3%
  • renal intercalated cell CL0005010
    CSI 1.2
    rCSI 11.1%
    PRS 29.5%
  • fibroblast CL0000057
    CSI 1.3
    rCSI 3.6%
    PRS 24.4%
  • cerebral cortex endothelial cell CL1001602
    CSI 1.3
    rCSI 2.2%
    PRS 2.3%
  • choroid plexus epithelial cell CL0000706
    CSI 1.3
    rCSI 2.1%
    PRS 2.4%
  • podocyte CL0000653
    CSI 1.3
    rCSI 5.7%
    PRS 3.1%
  • adventitial cell CL0002503
    CSI 1.3
    rCSI 3.1%
    PRS 4.9%
  • cord blood hematopoietic stem cell CL2000095
    CSI 1.3
    rCSI 25.7%
    PRS 26.0%
  • skeletal muscle satellite stem cell CL0008011
    CSI 1.4
    rCSI 6.3%
    PRS 12.5%
  • epithelial cell of esophagus CL0002252
    CSI 1.5
    rCSI 14.7%
    PRS 12.6%
  • enteroendocrine cell of colon CL0009042
    CSI 1.6
    rCSI 7.6%
    PRS 8.5%
  • glutamatergic neuron CL0000679
    CSI 1.7
    rCSI 3.4%
    PRS 3.6%
  • follicular B cell CL0000843
    CSI 1.7
    rCSI 6.1%
    PRS 15.7%
  • kidney distal convoluted tubule epithelial cell CL1000849
    CSI 1.7
    rCSI 18.1%
    PRS 5.3%
  • vasa recta ascending limb cell CL1001131
    CSI 1.7
    rCSI 7.7%
    PRS 14.6%
  • mesenchymal lymphangioblast CL0005021
    CSI 1.7
    rCSI 45.7%
    PRS 17.1%
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 1.8
    rCSI 2.5%
    PRS 2.9%
  • ciliated cell CL0000064
    CSI 1.8
    rCSI 3.0%
    PRS 3.1%
  • GABAergic neuron CL0000617
    CSI 1.9
    rCSI 6.3%
    PRS 3.0%
  • transitional stage B cell CL0000818
    CSI 1.9
    rCSI 6.2%
    PRS 9.5%
  • acinar cell of salivary gland CL0002623
    CSI 2.0
    rCSI 47.3%
    PRS 3.4%
  • endocrine cell CL0000163
    CSI 2.0
    rCSI 10.5%
    PRS 14.6%
  • renal principal cell CL0005009
    CSI 2.1
    rCSI 5.3%
    PRS 4.5%
  • neuroendocrine cell CL0000165
    CSI 2.1
    rCSI 8.0%
    PRS 6.6%
  • memory T cell CL0000813
    CSI 2.2
    rCSI 4.2%
    PRS 6.9%
  • follicular dendritic cell CL0000442
    CSI 2.2
    rCSI 35.4%
    PRS 20.5%
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 2.3
    rCSI 1.4%
    PRS 4.2%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [H2AZ1](/details-gene/3015), or H2A.Z variant histone 1, encodes a replication-independent histone H2A variant that is highly conserved evolutionarily [Link](https://pubmed.ncbi.nlm.nih.gov/3344202/). As a structural component of the nucleosome, [H2AZ1](/details-gene/3015) plays a fundamental role in '[chromatin organization](/details-cell/GO:0006325)' and the '[positive regulation of transcription by rna polymerase ii](/details-cell/GO:0045944)'. Its primary function involves replacing conventional H2A in nucleosomes, particularly at gene promoters and enhancers, to modulate chromatin structure and accessibility for transcription factors. Expression data indicates that **Overall**, [H2AZ1](/details-gene/3015) is most significant in highly proliferative and multipotent cell populations, such as hematopoietic progenitors and stem cells, suggesting a crucial role in maintaining cellular plasticity and directing lineage commitment. Conversely, its expression is markedly low in terminally differentiated cells like mature T cells and neurons, highlighting its specific association with developmental processes rather than the maintenance of differentiated states. ## Cellular Roles and Expression Landscape The expression profile of [H2AZ1](/details-gene/3015) underscores its central role in cell proliferation, differentiation, and the maintenance of progenitor cell states. **Overall**, the gene shows the highest significance in various progenitor cell types within the hematopoietic system. These include [granulocyte monocyte progenitor cell](/details-cell/CL0000557) (CSI: 114.76), [common myeloid progenitor](/details-cell/CL0000049) (CSI: 114.49), [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050) (CSI: 96.45), and [hematopoietic stem cell](/details-cell/CL0000037) (CSI: 84.98). Its significance extends to lymphoid progenitors as well, such as [pro-B cell](/details-cell/CL0000826) and [early lymphoid progenitor](/details-cell/CL0000936). Beyond hematopoiesis, [H2AZ1](/details-gene/3015) is also a key marker in other highly proliferative or multipotent populations, including [neuroblast (sensu Nematoda and Protostomia)](/details-cell/CL0000338) (CSI: 94.19), [keratinocyte](/details-cell/CL0000312) (CSI: 90.03), and [transit amplifying cell of colon](/details-cell/CL0009011) (CSI: 73.95). This broad expression pattern in undifferentiated, rapidly dividing cells suggests that [H2AZ1](/details-gene/3015) is a key factor in establishing and maintaining an open chromatin environment that is permissive for the execution of complex developmental and cell fate programs. In stark contrast, [H2AZ1](/details-gene/3015) shows significantly low expression in terminally differentiated, post-mitotic cells. The most prominent anti-marker is the [alpha-beta T cell](/details-cell/CL0000789) (CSI: -53.28), indicating a sharp downregulation upon final immune cell maturation. Similarly, various neuronal subtypes, such as [pvalb GABAergic cortical interneuron](/details-cell/CL4023018) and [L5 extratelencephalic projecting glutamatergic cortical neuron](/details-cell/CL4023041), as well as glial cells like [astrocyte of the cerebral cortex](/details-cell/CL0002605), exhibit low to negative CSI scores. This pattern strongly suggests that the removal or downregulation of [H2AZ1](/details-gene/3015) is a feature of terminal differentiation, where the cellular state becomes fixed and plasticity is reduced. ## Pathways and Molecular Function Functionally, [H2AZ1](/details-gene/3015) is integral to chromatin dynamics. As a '[structural constituent of chromatin](/details-cell/GO:0030527)', it is incorporated into '[nucleosome](/details-cell/GO:0000786)' structures where it can influence gene expression. Its involvement in '[positive regulation of transcription by rna polymerase ii](/details-cell/GO:0045944)' is consistent with its role in maintaining active or poised promoters in progenitor cells, facilitating rapid transcriptional responses to differentiation cues. This is supported by studies showing that H2A.Z is exchanged at specific gene promoters during transcriptional activation [Link](https://doi.org/10.1074/jbc.m501784200). Molecularly, [H2AZ1](/details-gene/3015) exerts its function through '[chromatin dna binding](/details-cell/GO:0031490)' and '[protein heterodimerization activity](/details-cell/GO:0046982)' with other histones, primarily H2B. The gene is also associated with processes such as '[heterochromatin formation](/details-cell/GO:0031507)' and is found in the '[euchromatin](/details-cell/GO:0000791)', indicating a dual role in both gene silencing and activation depending on the genomic context and post-translational modifications. Furthermore, its annotation in the '[Metabolism of proteins](/details-cell/R-HSA-392499)' Reactome pathway reflects its nature as a core protein that is synthesized, modified, and incorporated into chromatin. The association with '[Amyloid fiber formation](/details-cell/R-HSA-977225)' is less characterized but may point towards roles in protein aggregation under certain pathological conditions. ## Research Directions The striking contrast in [H2AZ1](/details-gene/3015) significance between progenitor and terminally differentiated cells provides a fertile ground for investigation into the mechanisms of cell fate determination and its potential dysregulation in disease. **Proposed Hypotheses:** 1. The downregulation of [H2AZ1](/details-gene/3015) is a necessary prerequisite for the terminal differentiation of hematopoietic lineages. Its forced, sustained expression in progenitor cells, such as the [common myeloid progenitor](/details-cell/CL0000049), would arrest their development and prevent maturation into functional, differentiated cells like macrophages or granulocytes. 2. In cancers characterized by a de-differentiated or stem-like phenotype, [H2AZ1](/details-gene/3015) is aberrantly re-expressed or overexpressed to maintain a proliferative, plastic state. Its levels would correlate with tumor grade and poor differentiation status, particularly in hematological malignancies or carcinomas. **Experimental Approach:** To test the first hypothesis, one could employ a CRISPR-based activation (CRISPRa) system or a doxycycline-inducible lentiviral vector to enforce sustained overexpression of [H2AZ1](/details-gene/3015) in primary human [hematopoietic stem cell](/details-cell/CL0000037)s (HSPCs). These modified HSPCs would then be cultured in differentiation-inducing media for myeloid and lymphoid lineages. The primary readouts would be flow cytometry analysis to quantify the proportions of mature cell markers (e.g., CD11b for myeloid, CD3 for T-cells) and single-cell RNA sequencing (scRNA-seq) to precisely map the developmental stage at which differentiation is arrested compared to control cells. **Therapeutic Potential:** As an intracellular nuclear protein, [H2AZ1](/details-gene/3015) itself is not a conventionally druggable target for antibodies. However, its crucial role in maintaining progenitor and cancer stem cell states makes the pathways that regulate its deposition into chromatin highly attractive therapeutic targets. The enzymatic complexes responsible for H2A.Z exchange, such as SRCAP, are promising candidates for small molecule inhibition. A therapeutic strategy would focus on **inhibition** of the H2A.Z deposition machinery, which could potentially force differentiation and halt the proliferation of cancer cells that are dependent on the chromatin plasticity conferred by [H2AZ1](/details-gene/3015). This approach could be particularly effective in treating poorly differentiated cancers or overcoming resistance mechanisms associated with cancer stem cells.

Genular Protein ID: 3343180047

Symbol: H2AZ_HUMAN

Name: Histone H2A.Z

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 3344202

Title: Sequence of cDNAs for mammalian H2A.Z, an evolutionarily diverged but highly conserved basal histone H2A isoprotein species.

PubMed ID: 3344202

DOI: 10.1093/nar/16.3.1113

PubMed ID: 1697587

Title: The human histone H2A.Z gene. Sequence and regulation.

PubMed ID: 1697587

DOI: 10.1016/s0021-9258(18)77243-8

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 15815621

Title: Generation and annotation of the DNA sequences of human chromosomes 2 and 4.

PubMed ID: 15815621

DOI: 10.1038/nature03466

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 11835281

Title: Histone ubiquitination: a tagging tail unfolds?

PubMed ID: 11835281

DOI: 10.1002/bies.10038

PubMed ID: 15878876

Title: Transcription-induced chromatin remodeling at the c-myc gene involves the local exchange of histone H2A.Z.

PubMed ID: 15878876

DOI: 10.1074/jbc.m501784200

PubMed ID: 16457589

Title: Precise characterization of human histones in the H2A gene family by top down mass spectrometry.

PubMed ID: 16457589

DOI: 10.1021/pr050269n

PubMed ID: 16627869

Title: Quantitative proteomic analysis of post-translational modifications of human histones.

PubMed ID: 16627869

DOI: 10.1074/mcp.m600007-mcp200

PubMed ID: 16319397

Title: Characterization of histones H2A and H2B variants and their post-translational modifications by mass spectrometry.

PubMed ID: 16319397

DOI: 10.1074/mcp.m500288-mcp200

PubMed ID: 19608861

Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.

PubMed ID: 19608861

DOI: 10.1126/science.1175371

PubMed ID: 20473270

Title: Essential role of p18Hamlet/SRCAP-mediated histone H2A.Z chromatin incorporation in muscle differentiation.

PubMed ID: 20473270

DOI: 10.1038/emboj.2010.85

PubMed ID: 26237645

Title: Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation.

PubMed ID: 26237645

DOI: 10.1038/ncb3209

PubMed ID: 28645917

Title: Multivalent binding of PWWP2A to H2A.Z regulates mitosis and neural crest differentiation.

PubMed ID: 28645917

DOI: 10.15252/embj.201695757

PubMed ID: 30327463

Title: PWWP2A binds distinct chromatin moieties and interacts with an MTA1-specific core NuRD complex.

PubMed ID: 30327463

DOI: 10.1038/s41467-018-06665-5

PubMed ID: 11101893

Title: Crystal structure of a nucleosome core particle containing the variant histone H2A.Z.

PubMed ID: 11101893

DOI: 10.1038/81971

PubMed ID: 24463511

Title: ANP32E is a histone chaperone that removes H2A.Z from chromatin.

PubMed ID: 24463511

DOI: 10.1038/nature12922

PubMed ID: 23324626

Title: SETD6 monomethylates H2AZ on lysine 7 and is required for the maintenance of embryonic stem cell self-renewal.

PubMed ID: 23324626

DOI: 10.4161/epi.23416

PubMed ID: 31527837

Title: DNA repair complex licenses acetylation of H2A.Z.1 by KAT2A during transcription.

PubMed ID: 31527837

DOI: 10.1038/s41589-019-0354-y

PubMed ID: 26974126

Title: Molecular basis and specificity of H2A.Z-H2B recognition and deposition by the histone chaperone YL1.

PubMed ID: 26974126

DOI: 10.1038/nsmb.3189

PubMed ID: 31645732

Title: Metabolic regulation of gene expression by histone lactylation.

PubMed ID: 31645732

DOI: 10.1038/s41586-019-1678-1

Sequence Information:

  • Length: 128
  • Mass: 13553
  • Checksum: E024E53818230371
  • Sequence:
  • MAGGKAGKDS GKAKTKAVSR SQRAGLQFPV GRIHRHLKSR TTSHGRVGAT AAVYSAAILE 
    YLTAEVLELA GNASKDLKVK RITPRHLQLA IRGDEELDSL IKATIAGGGV IPHIHKSLIG 
    KKGQQKTV